跳至主要内容
临床试验/CTRI/2024/07/069772
CTRI/2024/07/069772尚未招募3 期

A controlled clinical study to evaluate the efficacy of Vranaropani (Hemigraphis alternata (Burm.f)) Malahara in the management of sadyovrana. - nil

Dr Surender Redhu0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Patients of age group between 16 to 70 yrs.
  • Kshataja vrana, Chinna vrana.
  • Sadyovrana of following dimensions:
  • Maximum length 5 cm.
  • Maximum width: 5 cm
  • Maximum Depth: 0.5 cm.
  • Patients of either gender.
  • Wounds within 7 days.

排除标准

  • Patients with systemic disorders like DM, HTN, Bleeding disorders and dermatological manifestations.
  • Wounds that require suturing.
  • Dushta Vrana (Infected).
  • The patients having Sadyovrana with other complications like fractures Marmaghata etc.
  • Medico-legal cases

研究者

发起方
Dr Surender Redhu

相似试验

A comparitive clinical study of povidine ointment... | 临床试验